Christoph Westphal

Fondateur chez Longwood Fund Management LLC

Profil

Christoph H.
Westphal founded Concert Pharmaceuticals, Inc. in 2006, Sirtris Pharmaceuticals, Inc. in 2004, where he worked as President & Chief Executive Officer from 2004 to 2010, Nanosys, Inc. in 2001, and various other companies.
Dr. Westphal also founded DEM BioPharma, Inc., Alnylam Pharmaceuticals, Inc., where he worked as Vice Chairman, and Newleos Therapeutics, Inc., where he is working as Director from 2026.
Dr. Westphal also currently works at Immunitas Therapeutics, Inc., as Chairman from 2019, Recros Medica, Inc., as Director from 2018, Solu Therapeutics, Inc., as Director, and various other companies.
Dr. Westphal also formerly worked at Saegis Pharmaceuticals, Inc., as Director, Werewolf Therapeutics, Inc., as Director, Pyxis Oncology, Inc., as Director, and various other companies.
Dr. Westphal received his undergraduate degree from The Trustees of Columbia University in The City of New York, doctorate degree from Harvard University, and doctorate degree from Harvard Medical School.

Postes actifs de Christoph Westphal

Sociétés	Poste	Début
Longwood Fund Management LLC	Fondateur	01/02/2010
Longwood Fund II GP LLC	Corporate Officer/Principal	-
Longwood Fund LP	Corporate Officer/Principal	01/01/2010
Boston Symphony Orchestra, Inc.	Directeur/Membre du Conseil	-
Commercial Club of Boston	Corporate Officer/Principal	-
Recros Medica, Inc.	Directeur/Membre du Conseil	04/01/2018
Immunitas Therapeutics, Inc.	Président	18/12/2019
ImmuneID, Inc.	Fondateur	07/10/2020
Solu Therapeutics	Directeur/Membre du Conseil	-

Anciens postes connus de Christoph Westphal

Sociétés	Poste	Fin
░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░░░	░░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░	░░░░░░░░░	░░░░░░░░░░